Programma sepsis
(?). Francesco Scaglione (Milano) 16.15 Advantages and disadvantages of fosfomycin as a “partner” for EAT. Stefano Di Bella (Trieste) 16.30 Discussione PROGNOSIS AND PERSONALIZED MEDICINE Chairmen: Michael Klompas (Boston), Chanu Rhee (Boston), Jean Louis-Vincent (Bruxelles) 16.40 Dow we need (new) serum ...